本页面由Tiger Trade Technology Pte. Ltd.提供服务

Forte BioSciences Inc

33.61
+3.9513.32%
成交量:26.80万
成交额:856.75万
市值:4.21亿
市盈率:-7.65
高:33.61
开:29.46
低:29.25
收:29.66
52周最高:33.61
52周最低:4.90
股本:1,252.69万
流通股本:926.19万
量比:1.38
换手率:2.89%
股息:- -
股息率:- -
每股收益(TTM):-4.3909
每股收益(LYR):-12.1671
净资产收益率:-110.72%
总资产收益率:-58.07%
市净率:5.01
市盈率(LYR):-2.76

数据加载中...

2022/05/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/01

重要事件披露

8-K - Current report
2022/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/18

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/02

重要事件披露

8-K - Current report
2021/09/16

超过5%披露

Forte Biosciences, Inc.
2021/09/08

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/07

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/06/04

重要事件披露

8-K - Current report
2021/06/03

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/18

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/10

重要事件披露

8-K - Current report
2021/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals